top of page


Semaglutide – the first type 2 diabetes oral pill in its class
Diabetes is a global epidemic affecting around 463 million adults worldwide (1). India is considered the diabetes capital of the world. Around 69.9 million patients are expected to be suffering from Type 2 diabetes by 2025. This is projected to increase to 80 million by 2023 which is a 266% increase (2). Current treatment guidelines recommend lifestyle changes, such as diet and exercise along with pharmacotherapy. Metformin is considered as gold standard and is routinely pres

Dr. Lokesh Naik
Sep 10, 20254 min read
bottom of page